Length of stay of COPD hospital admissions between 2006 and 2010: A retrospective longitudinal study

International Journal of COPD

Volumn 10, Issue , 2015, Pages 603-611

  Harries, Timothy H ^a   Thornton, Hannah V ^b   Crichton, Siobhan ^a   Schofield, Peter ^a   Gilkes, Alexander ^a   White, Patrick T ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

General practice; Hospitalization; LOS

Indexed keywords

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEMALE; GENERAL PRACTICE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; LENGTH OF STAY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; REGISTER; RETROSPECTIVE STUDY; SOCIOECONOMICS; UNITED KINGDOM; ADULT; DISEASE COURSE; ENGLAND; HEALTH; HOSPITAL EMERGENCY SERVICE; MIDDLE AGED; OUT-OF-HOURS CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TIME FACTOR; TRENDS;

ADULT; AFTER-HOURS CARE; DISEASE PROGRESSION; EMERGENCY SERVICE, HOSPITAL; FEMALE; GENERAL PRACTICE; HUMANS; LENGTH OF STAY; LONDON; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PATIENT ADMISSION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; URBAN HEALTH;

EID: 84929417404     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S77092     Document Type: Article

References (40)

1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442.
2. National Clinical Guideline Centre (UK). Chronic Obstructive Pulmonary Disease: Management of Chronic Obstructive Pulmonary Disease in Adults in Primary and Secondary Care. London, UK: Royal College of Physicians; 2010. Available from: http://www.ncbi.nlm.nih.gov/books/NBK65043/. Accessed September 17, 2014.
3. Britton M. The burden of COPD in the U.K.: results from the Confronting COPD survey. Respir Med. 2003;97 Suppl C:S71–S79.
4. Halpin DM, Miravitlles M. Chronic obstructive pulmonary disease: the disease and its burden to society. Proc Am Thorac Soc. 2006;3(7):619–623.
5. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57(10):847–852.
6. Niewoehner DE. The impact of severe exacerbations on quality of life and the clinical course of chronic obstructive pulmonary disease. Am J Med. 2006;119(10 Suppl 1):38–45.
7. Suissa S, Dell’Aniello S, Ernst P. Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax. 2012;67(11):957–963.
8. Soler-Cataluña JJ, Martínez-García MÁ, Román Sánchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925–931.
9. Crockett AJ, Cranston JM, Moss JR, Alpers JH. An association between length of stay and co-morbidity in chronic airflow limitation. Int J Qual Health Care. 2000;12(1):41–46.
10. Department of Health (UK). Consultation on a Strategy for Services for Chronic Obstructive Pulmonary Disease (COPD) in England. London, UK: Department of Health; 2010. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/213840/dh_113279.pdf. Accessed January 5, 2014.
11. Agboado G, Peters J, Donkin L. Factors influencing the length of hospital stay among patients resident in Blackpool admitted with COPD: a cross-sectional study. BMJ Open. 2012;2(5). pii: e000869.
12. Roberts CM, Stone RA, Lowe D, Pursey NA, Buckingham RJ. Co-morbidities and 90-day outcomes in hospitalized COPD exacerbations. COPD. 2011;8(5):354–361.
13. Tsimogianni AM, Papiris SA, Stathopoulos GT, Manali ED, Roussos C, Kotanidou A. Predictors of outcome after exacerbation of chronic obstructive pulmonary disease. J Gen Intern Med. 2009;24(9):1043–1048.
14. Baker EH, Janaway CH, Philips BJ, et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax. 2006;61(4):284–289.
15. Burt MG, Roberts GW, Aguilar-Loza NR, Quinn SJ, Frith PA, Stranks SN. Relationship between glycaemia and length of hospital stay during an acute exacerbation of chronic obstructive pulmonary disease. Intern Med J. 2013;43(6):721–724.
16. Wong AW, Gan WQ, Burns J, Sin DD, van Eeden SF. Acute exacerbation of chronic obstructive pulmonary disease: influence of social factors in determining length of hospital stay and readmission rates. Can Respir J. 2008;15(7):361–364.
17. Wang Y, Stavem K, Dahl FA, Humerfelt S, Haugen T. Factors associated with a prolonged length of stay after acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Int J Chron Obstruct Pulmon Dis. 2014;9:99–105.
18. George PM, Stone RA, Buckingham RJ, Pursey NA, Lowe D, Roberts CM. Changes in NHS organization of care and management of hospital admissions with COPD exacerbations between the national COPD audits of 2003 and 2008. QJM. 2011;104(10):859–866.
19. Price LC, Lowe D, Hosker HSR, Anstey K, Pearson MG, Roberts CM. UK National COPD Audit 2003: impact of hospital resources and organisation of care on patient outcome following admission for acute COPD exacerbation. Thorax. 2006;61(10):837–842.
20. Connolly MJ, Lowe D, Anstey K, Hosker HS, Pearson MG, Roberts CM. Admissions to hospital with exacerbations of chronic obstructive pulmonary disease: effect of age related factors and service organisation. Thorax. 2006;61(10):843–848.
21. Hosker H, Anstey K, Lowe D, Pearson M, Roberts CM. Variability in the organisation and management of hospital care for COPD exacerbations in the UK. Respir Med. 2007;101(4):754–761.
22. Kastelik JA, Lowe D, Stone RA, Buckingham RJ, Roberts CM. National audit of supported discharge programmes for management of acute exacerbations of chronic obstructive pulmonary disease 2008. Thorax. 2012;67(4):371–373.
23. Fitzpatrick J, Jacobson B. Mapping Inequalities across London. London Health Observatory at the King’s Fund; 2001.
24. Hospital Episode Statistics [webpage on the Internet]. Leeds, UK: NHS Information Centre; 2014. Available from: http://www.hscic.gov.uk/hes. Accessed January 5, 2014.
25. Holt PJ, Sinha S, Ozdemir BA, Karthikesalingam A, Poloniecki JD, Thompson MM. Variations and inter-relationship in outcome from emergency admissions in England: a retrospective analysis of Hospital Episode Statistics from 2005–2010. BMC Health Serv Res. 2014;14:270.
26. Payne RA, Abel GA. UK indices of multiple deprivation – a way to make comparisons across constituent countries easier. Health Stat Q Off Natl Stat. 2012;(53):22-37.
27. Purdy S, Griffin T, Salisbury C, Sharp D. Emergency respiratory admissions: influence of practice, population and hospital factors. J Health Serv Res Policy. 2011;16(3):133–140.
28. Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359(15):1543–1554.
29. Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356(8):775–789.
30. Calverley P, Pauwels R, Vestbo J, et al; TRial of Inhaled STeroids ANd long-acting beta2 agonists study group. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet. 2003;361(9356):449–456.
31. Wedzicha JA, Calverley PM, Seemungal TA, Hagan G, Ansari Z, Stockley RA; INSPIRE Investigators. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med. 2008;177(1):19–26.
32. Vijayasaratha K, Stockley RA. Relationship between frequency, length, and treatment outcome of exacerbations to baseline lung function and lung density in alpha-1 antitrypsin-deficient COPD. Int J Chron Obstruct Pulmon Dis. 2012;7:789–796.
33. De Miguel-Díez J, Jiménez-García R, Hernández-Barrera V, et al. Trends in hospital admissions for acute exacerbation of COPD in Spain from 2006 to 2010. Respir Med. 2013;107(5):717–723.
34. Quintana JM, Unzurrunzaga A, Garcia-Gutierrez S, et al; IRYSS-COPD Group. Predictors of hospital length of stay in patients with exacerbations of COPD: a cohort study. J Gen Intern Med. Epub 2014 Dec 4.
35. National Health Service Commissioning Board. Everyone Counts: Planning for Patients 2013/14. Redditch, UK; National Health Service. Available from: http://www.england.nhs.uk/wp-content/uploads/2012/12/everyonecounts-planning.pdf. Accessed January 5, 2014.
36. Aylin P, Yunus A, Bottle A, Majeed A, Bell D. Weekend mortality for emergency admissions. A large, multicentre study. Qual Saf Health Care. 2010;19(3):213–217.
37. Handel AE, Patel SV, Skingsley A, Bramley K, Sobieski R, Ramagopalan SV. Weekend admissions as an independent predictor of mortality: an analysis of Scottish hospital admissions. BMJ Open. 2012;2(6) :pii. e001789.
38. Barba R, Zapatero A, Losa JE, et al. The impact of weekends on outcome for acute exacerbations of COPD. Eur Respir J. 2012;39(1):46–50.
39. Hawkins NM, Jhund PS, Simpson CR, et al. Primary care burden and treatment of patients with heart failure and chronic obstructive pulmonary disease in Scotland. Eur J Heart Fail. 2010;12(1):17–24.
40. Audit Commission. Improving Data Quality in the NHS: 2010. Annual Report on the PbR Assurance Programme. London, UK: Audit Commission; 2010. Available from: http://archive.audit-commission.gov.uk/auditcommission/sitecollectiondocuments/Downloads/26082010pbrnhsdataqualityreport.pdf. Accessed January 5, 2014.